Abstract:Background: Myeloid differentiation factor 88 (MyD88) is the core adaptor for Toll-like receptors defending against microbial invasion and initiating a downstream immune response during microbiota-host interaction. However, the role of MyD88 in the pathogenesis of inflammatory bowel disease is controversial. This study aims to investigate the impact of MyD88 on intestinal inflammation and the underlying mechanism. Methods: MyD88 knockout (MyD88-/-) mice and the MyD88 inhibitor (TJ-M2010-5) were used to investigate the impact of MyD88 on acute dextran sodium sulfate (DSS)-induced colitis. Disease activity index, colon length, histological score, and inflammatory cytokines were examined to evaluate the severity of colitis. RNA transcriptome analysis and 16S rDNA sequencing were used to detect the potential mechanism. Results: In an acute DSS-colitis model, the severity of colitis was not alleviated in MyD88-/- mice and TJ-M2010-5-treated mice, despite significantly lower levels of NF-κB activation being exhibited compared to control mice. Meanwhile, 16S rDNA sequencing and RNA transcriptome analysis revealed a higher abundance of intestinal Proteobacteria and an up-regulation of the nucleotide oligomerization domain-like receptors (NLRs) signaling pathway in colitis mice following MyD88 suppression. Further blockade of the NLRs signaling pathway or elimination of gut microbiota with broad-spectrum antibiotics in DSS-induced colitis mice treated with TJ-M2010-5 ameliorated the disease severity, which was not improved solely by MyD88 inhibition. After treatment with broad-spectrum antibiotics, downregulation of the NLR signaling pathway was observed. Conclusion: Our study suggests that the suppression of MyD88 might be associated with unfavorable changes in the composition of gut microbiota, leading to NLR-mediated immune activation and intestinal inflammation.

Targeted disruption of the MyD88 gene results in loss of IL-1-and IL-18-mediated function

Unresponsiveness of MyD88-deficient mice to endotoxin

IL-1 Receptor-Mediated Signal is an Essential Component of MyD88-dependent Innate Response to Mycobacterium Tuberculosis Infection.

Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades

The Dual Functions of IL-1 Receptor-Associated Kinase 2 in TLR9-Mediated IFN and Proinflammatory Cytokine Production

MyD 88 Intrinsically Regulates CD 4 T-Cell Responses

Defective NK cell activity and Th1 response in IL-18–deficient mice

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway

IRAK-M Mediates Toll-like Receptor/il-1R-induced NFκB Activation and Cytokine Production

Myd88 is Critical for the Development of Innate and Adaptive Immunity During Acute Lymphocytic Choriomeningitis Virus Infection

Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor

Suppression of MyD88 disturbs gut microbiota and activates the NLR pathway and hence fails to ameliorate DSS-induced colitis

Protein phosphatase 2A catalytic subunit α plays a MyD88-dependent, central role in the gene-specific regulation of endotoxin tolerance.

Aa155-171 Motif Deletion of MyD88 Attenuates Expression of Co-stimulatory Molecules and Cytokines in Immune Associated-cells

Incomplete Knockdown of MyD88 Inhibits LPS-Induced Lung Injury and Lung Fibrosis in a Mouse Model.

Identification of Lps2 As a Key Transducer of MyD88-independent TIR Signalling.

MyD88 signaling regulates both host defense and immunopathogenesis during pneumocystis infection

Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice

Natural Killer Cell Intrinsic Toll-Like Receptor MyD88 Signaling Contributes to IL-12-dependent IFN-γ Production by Mice During Infection with Toxoplasma Gondii.

Homeostatic Defects in Interleukin 18-Deficient Mice Contribute to Protection Against the Lethal Effects of Endotoxin.

MyD88 protein destabilization mitigates NF-κB-dependent protection against macrophage apoptosis